Literature DB >> 11497540

Clinical investigators--the endangered species revisited.

E D Miller.   

Abstract

Mesh：

Year:  2001        PMID： 11497540     DOI： 10.1001/jama.286.7.845

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  General Clinical Research Centers in the United States make a healthy recovery.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2001-11-15       Impact factor: 4.599

2.  Resident research and scholarly activity in internal medicine residency training programs.

Authors:  Rachel B Levine; Randy S Hebert; Scott M Wright
Journal:  J Gen Intern Med       Date:  2005-02       Impact factor: 5.128

Review 3.  FDA critical path initiatives: opportunities for generic drug development.

Authors:  Robert A Lionberger
Journal:  AAPS J       Date:  2008-02-20       Impact factor: 4.009

4.  Mentoring the next generation of physician-scientists in Japan: a cross-sectional survey of mentees in six academic medical centers.

Authors:  Ken Sakushima; Hiroki Mishina; Shunichi Fukuhara; Kenei Sada; Junji Koizumi; Takashi Sugioka; Naoto Kobayashi; Masaharu Nishimura; Junichiro Mori; Hirofumi Makino; Mitchell D Feldman
Journal:  BMC Med Educ       Date:  2015-03-19       Impact factor: 2.463

5.  Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database.

Authors:  Christopher B Fordyce; Matthew T Roe; Christine Pierre; Terri Hinkley; Gerrit Hamre; Pamela Tenaerts; Jonathan McCall; James D Topping
Journal:  Contemp Clin Trials Commun       Date:  2019-05-21

6.  One and done: Reasons principal investigators conduct only one FDA-regulated drug trial.

Authors:  Amy Corneli; Christine Pierre; Terri Hinkley; Li Lin; Christopher B Fordyce; Gerrit Hamre; Matthew T Roe
Journal:  Contemp Clin Trials Commun       Date:  2017-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.